Last reviewed · How we verify

NCT06859827

Role of CMR-FT in Assessment of HCM and Athlete's Heart.

Active, enrolled Last updated 5 March 2025
What this trial tests

trial in Hypertrophic Cardiomyopathies in 50 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 December 2024
Primary endpoint
15 November 2025
15 December 2025

Quick facts

Lead sponsorSohag University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment50
Start date15 December 2024
Primary completion15 November 2025
Estimated completion15 December 2025
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

Adults 20 to 50, any sex, with Hypertrophic Cardiomyopathies or Athlete Heart. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using cardiac MRI feature tracking to asses myocardial motion differences in athlete's heart and discovered hypertrophic cardiomyopathy patients to increase diagnostic accuracy of hypertrophic cardiomyopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertrophic Cardiomyopathies

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06859827.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing